Toulouse, may 29, 2017 (18:00 CEST) – VEXIM (FR0011072602 – ALVXM / eligible PEA-PME), a medical device company, specializing in the treatment for minimally invasive vertebral fractures, announces today that it has received regulatory approval from ANVISA[1], the national agency of sanitary surveillance in Brazil, to market the SpineJack®.
Download the free guide
Boost your gains
The approval by ANVISA is a key step for VEXIM opens up a new opportunity of development on a foreign market with high potential and still untapped. This recording brings to VEXIM new growth prospects in the key market of Latin America. VEXIM is estimated that Brazil represents today, alone, a market of 15 million euros in the field of vertebral compression fractures.
“This approval will contribute to the ongoing growth of our international activities. We plan to launch the export of the SpineJack® in Brazil in the coming months, after the completion of the evaluation process and the signing of distribution partnerships, ” commented Vincent Gardès, ceo of VEXIM
Agenda projected financial communication :
Turnover of 2nd quarter 2017 July 11, 2017[2]
About VEXIM, the specialist in the microsurgery innovative back
Based in Balma, near Toulouse, VEXIM is a medical device company founded in February 2006. Company expert in the trauma of the spine (low-and high-energy, tumor), VEXIM has specialised in the creation and commercialization of solutions for minimally-invasive to treat the pathology of trauma of the spine. Benefiting from the financial support of the shareholder of long-time Truffle Capital, [3], as well as government grants BPI, VEXIM has designed and developed the SpineJack®, a unique implant capable of repairing a fractured vertebra and restoring the balance of the spine. She has also designed the MasterflowTM, a mixer-injector of orthopedic cement of innovation which improves the accuracy of the injection, and optimizes the surgical procedure. The Company currently has 66 employees and has its own sales teams in Europe and a network of specialized distributors internationally. VEXIM has been listed on the market Alternext Paris since may 2012. For more information, visit www.vexim.com
SpineJack®[4], an implant revolutionary for the treatment of vertebral fractures
The revolutionary aspect of the SpineJack® lies in its ability to restore a fractured vertebra to its original shape, restore the anatomy is optimal to the spine and thus neutralize the pain and ensure recovery of the functional capacity of the patient. Thanks to a specialized range of instruments, inserting the implants into the vertebra is carried out using a minimally invasive surgery, under x-ray control in approximately 30 minutes, which allows the patient to get out shortly after the operation. The range of SpineJack® consists of 3 titanium implants of 3 different diameters, thus covering 95 % of vertebral fractures and all of the morphologies of the patients. The technology SpineJack® benefits from the support of expert international scientists in the field of surgery of the spine and a patent protection throughout the world until 2029.
Download the free guide
Boost your gains
